Electronic Prescriptions for Controlled Substances Notice of Approved Certification Process, 18364-18365 [2013-06918]
Download as PDF
<![CDATA[
18364
Federal Register / Vol. 78, No. 58 / Tuesday, March 26, 2013 / Notices
reappointment of Daniel J. Little may
submit written comments to the address
listed above. Comments must be
received by April 25, 2013.
Dated: March 20, 2013.
Ken Salazar,
Secretary.
[FR Doc. 2013–06853 Filed 3–25–13; 8:45 am]
BILLING CODE 4310–10–P
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms
and Explosives
[OMB Number 1140–0004]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Interstate
Firearms Shipment Report of
Theft/Loss
srobinson on DSK4SPTVN1PROD with NOTICES
ACTION:
60-Day notice.
The Department of Justice (DOJ),
Bureau of Alcohol, Tobacco, Firearms
and Explosives (ATF), will submit the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection is published to
obtain comments from the public and
affected agencies. Comments are
encouraged and will be accepted for
‘‘sixty days’’ until [insert the date 60
days from the date this notice is
published in the Federal Register]. This
process is conducted in accordance with
5 CFR 1320.10.
If you have comments especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Ben Hayes,
Benjamin.Hayes@atf.gov, ATF National
Tracing Center, 244 Needy Road,
Martinsburg, WV 25405.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
VerDate Mar<15>2010
19:07 Mar 25, 2013
Jkt 229001
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Summary of Information Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Interstate Firearms Shipment Report of
Theft/Loss.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: ATF F 3310.6.
Bureau of Alcohol, Tobacco, Firearms
and Explosives.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: None.
Need for Collection
The form is part of a voluntary
program in which the common carrier
and/or shipper report losses or thefts of
firearms from interstate shipments. ATF
uses this information to ensure that the
firearms are entered into the National
Crime Information Center to initiate
investigations and to perfect criminal
cases.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 550
respondents will complete a 20 minute
form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 182
annual total burden hours associated
with this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Two Constitution
Square, 145 N Street NE., Room
3W–1407B, Washington, DC 20530.
Dated: March 20, 2013.
Jerri Murray,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. 2013–06779 Filed 3–25–13; 8:45 am]
BILLING CODE 4810–FY–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–364]
Electronic Prescriptions for Controlled
Substances Notice of Approved
Certification Process
Drug Enforcement
Administration (DEA), Department of
Justice.
ACTION: Notice.
AGENCY:
SUMMARY: DEA is announcing two new
DEA-approved certification processes
for providers of Electronic Prescriptions
for Controlled Substances (EPCS)
applications. Certifying organizations
with a certification process approved by
DEA pursuant to 21 Code of Federal
Regulations (CFR) 1311.300(e) are
posted on DEA’s Web site upon
approval.
FOR FURTHER INFORMATION CONTACT: John
W. Partridge, Executive Assistant, Office
of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152; Telephone: (202) 307–7165.
SUPPLEMENTARY INFORMATION:
Background
The Drug Enforcement
Administration (DEA) implements and
enforces Titles II and III of the
Comprehensive Drug Abuse Prevention
and Control Act of 1970 and the
Controlled Substances Import and
Export Act (21 U.S.C. 801–971), as
amended, and referred to as the
Controlled Substances Act (CSA).1 DEA
publishes the implementing regulations
for these statutes in Title 21 of the Code
of Federal Regulations (CFR), Parts 1300
to 1321. The CSA and its implementing
regulations are designed to prevent,
detect, and eliminate the diversion of
controlled substances and listed
chemicals into the illicit market while
ensuring a sufficient supply of
controlled substances and listed
chemicals for legitimate medical,
scientific, research, and industrial
purposes.
The CSA and DEA’s implementing
regulations establish the legal
requirements for possessing and
dispensing controlled substances,
including the issuance of a prescription
for a legitimate medical purpose by a
practitioner acting in the usual course of
professional practice. ‘‘The
responsibility for the proper prescribing
and dispensing of controlled substances
is upon the prescribing practitioner, but
1 The Attorney General’s delegation of authority
to DEA may be found at 28 CFR 0.100.
E:\FR\FM\26MRN1.SGM
26MRN1
Federal Register / Vol. 78, No. 58 / Tuesday, March 26, 2013 / Notices
a corresponding responsibility rests
with the pharmacist who fills the
prescription.’’ 21 CFR 1306.04(a). A
prescription serves both as a record of
the practitioner’s determination of the
legitimate medical need for the drug to
be dispensed, and as a record of the
dispensing. The prescription also
provides a record of the actual
dispensing of the controlled substance
to the ultimate user (the patient) and,
therefore, is critical to documenting that
controlled substances held by a
pharmacy have been properly
dispensed. The maintenance of
complete and accurate prescription
records is an essential part of the overall
CSA regulatory scheme established by
Congress.
Electronic Prescriptions for Controlled
Substances (EPCS)
Historically, where federal law
required that a prescription for a
controlled substance be issued in
writing, that requirement could only be
satisfied through the issuance of a paper
prescription. Given advancements in
technology and security capabilities for
electronic applications, DEA amended
its regulations to provide practitioners
with the option of issuing electronic
prescriptions for controlled substances
in lieu of paper prescriptions. Efforts to
develop EPCS capabilities have been
underway for a number of years. DEA’s
Interim Final Rule for Electronic
Prescriptions for Controlled Substances
was published on March 31, 2010, at 75
FR 16236–16319, and became effective
on June 1, 2010.
srobinson on DSK4SPTVN1PROD with NOTICES
Update
Certifying Organizations With a
Certification Process Approved by DEA
Pursuant to 21 CFR 1311.300(e)
As noted above, the Interim Final
Rule provides that, as an alternative to
the audit requirements of 21 CFR
1311.300(a) through (d), an electronic
prescription or pharmacy application
may be verified and certified as meeting
the requirements of 21 CFR Part 1311 by
a certifying organization whose
certification process has been approved
by DEA. The preamble to the Interim
Final Rule further indicated that, once
a qualified certifying organization’s
certification process has been approved
by DEA in accordance with 21 CFR
1311.300(e), such information will be
posted on DEA’s Web site. 75 FR 16243
(March 31, 2010). On January 18, 2013,
DEA approved the certification
processes developed by Global Sage
Group, LLC, and by iBeta, LLC. iBeta’s
certification process was previously
approved by DEA but only with regard
VerDate Mar<15>2010
19:07 Mar 25, 2013
Jkt 229001
to the certification of the application’s
biometrics subsystem, including its
interfaces. 77 FR 45688 (August 1,
2012). This approval for iBeta’s
certification process is expanded to
include the entire certification process.
Relevant information has been posted
on DEA’s Web site at https://
www.DEAdiversion.usdoj.gov.
Dated: March 20, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control.
[FR Doc. 2013–06918 Filed 3–25–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Foreign Claims Settlement
Commission
Commencement of Iraq Claims
Adjudication Program
Foreign Claims Settlement
Commission of the United States.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
commencement by the Foreign Claims
Settlement Commission
(‘‘Commission’’) of a program for
adjudication of a certain category of
claims of United States nationals against
the Government of Iraq, as defined
below, which were settled under the
‘‘Claims Settlement Agreement Between
the Government of the United States of
America and the Government of the
Republic of Iraq,’’ dated September 2,
2010 (‘‘Claims Settlement Agreement’’).
DATES: These claims can now be filed
with the Commission and the deadline
for filing will be June 26, 2013. The
deadline for completion of this claims
adjudication program will be March 26,
2014.
FOR FURTHER INFORMATION CONTACT:
Brian M. Simkin, Chief Counsel, Foreign
Claims Settlement Commission, 600 E
Street NW., Room 6002, Washington,
DC 20579, Tel. (202) 616–6975, FAX
(202) 616–6993.
Notice of Commencement of Claims
Adjudication Program, and of Program
Completion Date
Pursuant to the authority conferred
upon the Secretary of State and the
Commission under section 4(a)(1)(C) of
Title I of the International Claims
Settlement Act of 1949, as amended (22
U.S.C. 1623(a)(1)(C)), the Foreign Claims
Settlement Commission hereby gives
notice of the commencement of a
program for adjudication of a category of
claims of United States nationals against
the Government of Iraq. These claims,
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
18365
which have been referred to the
Commission by the Department of State
by letter dated November 14, 2012, are
defined as:
claims of U.S. nationals for compensation for
serious personal injuries knowingly inflicted
upon them by Iraq 1 in addition to amounts
already recovered under the Claims
Settlement Agreement for claims of hostagetaking 2 provided that (1) the claimant has
already received compensation under the
Claims Settlement Agreement from the
Department of State 3 for his or her claim of
hostage-taking, and such compensation did
not include economic loss based on a
judgment against Iraq, and (2) the
Commission determines that the severity of
the serious personal injury suffered is a
special circumstance warranting additional
compensation. For purposes of this referral,
‘‘serious personal injury’’ may include
instances of serious physical, mental, or
emotional injury arising from sexual assault,
coercive interrogation, mock execution, or
aggravated physical assault.
In conformity with the terms of the
referral, the Commission will determine
the claims in accordance with the
provisions of Title I of the International
Claims Settlement Act of 1949, as
amended, 22 U.S.C. 1621 et seq. The
Commission will then certify to the
Secretary of the Treasury those claims
that it finds to be valid, for payment out
of the claims fund established under the
Claims Settlement Agreement.
The Commission will administer this
claims adjudication program in
accordance with its regulations, which
are published in Chapter V of Title 45,
Code of Federal Regulations (45 CFR
500 et seq.). In particular, attention is
directed to 45 CFR 500.3(a), which
limits the amount of attorney’s fees that
may be charged for legal representation
before the Commission pursuant to 22
U.S.C. 1623(f). These regulations are
also available at https://
www.gpoaccess.gov/cfr/.
Approval has been obtained from the
Office of Management and Budget for
the collection of this information.
1 For purposes of this referral, ‘‘Iraq’’ shall mean
the Republic of Iraq, the Government of the
Republic of Iraq, any agency or instrumentality of
the Republic of Iraq, and any official, employee or
agent of the Republic of Iraq acting within the scope
of his or her office, employment or agency.
2 Hostage-taking, in this instance, would include
unlawful detention by Iraq that resulted in an
inability to leave Iraq or Kuwait after Iraq invaded
Kuwait on August 2, 1990.
3 The payment already received by the claimant
under the Claims Settlement Agreement
compensated the claimant for his or her experience
for the entire duration of the period in which the
claimant was held hostage or was subject to
unlawful detention and encompassed physical,
mental, and emotional injuries generally associated
with such captivity or detention.
E:\FR\FM\26MRN1.SGM
26MRN1
]]>Agencies
[Federal Register Volume 78, Number 58 (Tuesday, March 26, 2013)]
[Notices]
[Pages 18364-18365]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06918]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-364]
Electronic Prescriptions for Controlled Substances Notice of
Approved Certification Process
AGENCY: Drug Enforcement Administration (DEA), Department of Justice.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: DEA is announcing two new DEA-approved certification processes
for providers of Electronic Prescriptions for Controlled Substances
(EPCS) applications. Certifying organizations with a certification
process approved by DEA pursuant to 21 Code of Federal Regulations
(CFR) 1311.300(e) are posted on DEA's Web site upon approval.
FOR FURTHER INFORMATION CONTACT: John W. Partridge, Executive
Assistant, Office of Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701 Morrissette Drive, Springfield,
Virginia 22152; Telephone: (202) 307-7165.
SUPPLEMENTARY INFORMATION:
Background
The Drug Enforcement Administration (DEA) implements and enforces
Titles II and III of the Comprehensive Drug Abuse Prevention and
Control Act of 1970 and the Controlled Substances Import and Export Act
(21 U.S.C. 801-971), as amended, and referred to as the Controlled
Substances Act (CSA).\1\ DEA publishes the implementing regulations for
these statutes in Title 21 of the Code of Federal Regulations (CFR),
Parts 1300 to 1321. The CSA and its implementing regulations are
designed to prevent, detect, and eliminate the diversion of controlled
substances and listed chemicals into the illicit market while ensuring
a sufficient supply of controlled substances and listed chemicals for
legitimate medical, scientific, research, and industrial purposes.
---------------------------------------------------------------------------
\1\ The Attorney General's delegation of authority to DEA may be
found at 28 CFR 0.100.
---------------------------------------------------------------------------
The CSA and DEA's implementing regulations establish the legal
requirements for possessing and dispensing controlled substances,
including the issuance of a prescription for a legitimate medical
purpose by a practitioner acting in the usual course of professional
practice. ``The responsibility for the proper prescribing and
dispensing of controlled substances is upon the prescribing
practitioner, but
[[Page 18365]]
a corresponding responsibility rests with the pharmacist who fills the
prescription.'' 21 CFR 1306.04(a). A prescription serves both as a
record of the practitioner's determination of the legitimate medical
need for the drug to be dispensed, and as a record of the dispensing.
The prescription also provides a record of the actual dispensing of the
controlled substance to the ultimate user (the patient) and, therefore,
is critical to documenting that controlled substances held by a
pharmacy have been properly dispensed. The maintenance of complete and
accurate prescription records is an essential part of the overall CSA
regulatory scheme established by Congress.
Electronic Prescriptions for Controlled Substances (EPCS)
Historically, where federal law required that a prescription for a
controlled substance be issued in writing, that requirement could only
be satisfied through the issuance of a paper prescription. Given
advancements in technology and security capabilities for electronic
applications, DEA amended its regulations to provide practitioners with
the option of issuing electronic prescriptions for controlled
substances in lieu of paper prescriptions. Efforts to develop EPCS
capabilities have been underway for a number of years. DEA's Interim
Final Rule for Electronic Prescriptions for Controlled Substances was
published on March 31, 2010, at 75 FR 16236-16319, and became effective
on June 1, 2010.
Update
Certifying Organizations With a Certification Process Approved by DEA
Pursuant to 21 CFR 1311.300(e)
As noted above, the Interim Final Rule provides that, as an
alternative to the audit requirements of 21 CFR 1311.300(a) through
(d), an electronic prescription or pharmacy application may be verified
and certified as meeting the requirements of 21 CFR Part 1311 by a
certifying organization whose certification process has been approved
by DEA. The preamble to the Interim Final Rule further indicated that,
once a qualified certifying organization's certification process has
been approved by DEA in accordance with 21 CFR 1311.300(e), such
information will be posted on DEA's Web site. 75 FR 16243 (March 31,
2010). On January 18, 2013, DEA approved the certification processes
developed by Global Sage Group, LLC, and by iBeta, LLC. iBeta's
certification process was previously approved by DEA but only with
regard to the certification of the application's biometrics subsystem,
including its interfaces. 77 FR 45688 (August 1, 2012). This approval
for iBeta's certification process is expanded to include the entire
certification process. Relevant information has been posted on DEA's
Web site at https://www.DEAdiversion.usdoj.gov.
Dated: March 20, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control.
[FR Doc. 2013-06918 Filed 3-25-13; 8:45 am]
BILLING CODE 4410-09-P
